• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓源性抑制细胞在乳腺肿瘤微环境中响应血流和淋巴管内皮细胞相互作用而迁移。

Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment.

作者信息

Roberts LaDeidra Monét, Perez Matthew J, Balogh Kristen N, Mingledorff Garnett, Cross Janet V, Munson Jennifer M

机构信息

Department of Biomedical Engineering and Mechanics, Fralin Biomedical Research Institute, Virginia Tech, Roanoke, VA 24016, USA.

Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22904, USA.

出版信息

Cancers (Basel). 2022 Jun 18;14(12):3008. doi: 10.3390/cancers14123008.

DOI:10.3390/cancers14123008
PMID:35740673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9221529/
Abstract

At the site of the tumor, myeloid derived suppressor cells (MDSCs) infiltrate and interact with elements of the tumor microenvironment in complex ways. Within the invading tumor, MDSCs are exposed to interstitial fluid flow (IFF) that exists within the chronic inflammatory tumor microenvironment at the tumor-lymphatic interface. As drivers of cell migration and invasion, the link between interstitial fluid flow, lymphatics, and MDSCs have not been clearly established. Here, we hypothesized that interstitial fluid flow and cells within the breast tumor microenvironment modulate migration of MDSCs. We developed a novel 3D model to mimic the breast tumor microenvironment and incorporated MDSCs harvested from 4T1-tumor bearing mice. Using live imaging, we found that sorted GR1+ splenocytes had reduced chemotactic index compared to the unsorted population, but their speed and displacement were similar. Using our adapted tissue culture insert assay, we show that interstitial fluid flow promotes MDSC invasion, regardless of absence or presence of tumor cells. Coordinating with lymphatic endothelial cells, interstitial fluid flow further enhanced invasion of MDSCs in the presence of 4T1 cells. We also show that VEGFR3 inhibition reduced both MDSC and 4T1 flow response. Together, these findings indicate a key role of interstitial fluid flow in MDSC migration as well as describe a tool to explore the immune microenvironment in breast cancer.

摘要

在肿瘤部位,髓源性抑制细胞(MDSCs)浸润并以复杂的方式与肿瘤微环境的成分相互作用。在侵袭性肿瘤中,MDSCs暴露于肿瘤-淋巴界面处慢性炎症肿瘤微环境中存在的间质液流动(IFF)。作为细胞迁移和侵袭的驱动因素,间质液流动、淋巴管和MDSCs之间的联系尚未明确建立。在此,我们假设间质液流动和乳腺肿瘤微环境中的细胞调节MDSCs的迁移。我们开发了一种新型三维模型来模拟乳腺肿瘤微环境,并纳入了从携带4T1肿瘤的小鼠中收获的MDSCs。通过实时成像,我们发现与未分选的群体相比,分选的GR1+脾细胞趋化指数降低,但其速度和位移相似。使用我们改进的组织培养插入物试验,我们表明,无论是否存在肿瘤细胞,间质液流动都能促进MDSC的侵袭。与淋巴管内皮细胞协同作用,间质液流动在存在4T1细胞的情况下进一步增强了MDSCs的侵袭。我们还表明,VEGFR3抑制降低了MDSC和4T1的流动反应。总之,这些发现表明间质液流动在MDSC迁移中起关键作用,并描述了一种探索乳腺癌免疫微环境的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/c13988514489/cancers-14-03008-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/a726f40cadba/cancers-14-03008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/0780c51897c7/cancers-14-03008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/6eeebdd95267/cancers-14-03008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/f5426c32d41d/cancers-14-03008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/d4b62a3c5244/cancers-14-03008-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/c13988514489/cancers-14-03008-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/a726f40cadba/cancers-14-03008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/0780c51897c7/cancers-14-03008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/6eeebdd95267/cancers-14-03008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/f5426c32d41d/cancers-14-03008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/d4b62a3c5244/cancers-14-03008-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/9221529/c13988514489/cancers-14-03008-g006.jpg

相似文献

1
Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment.髓源性抑制细胞在乳腺肿瘤微环境中响应血流和淋巴管内皮细胞相互作用而迁移。
Cancers (Basel). 2022 Jun 18;14(12):3008. doi: 10.3390/cancers14123008.
2
Visualization and quantification of homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.可视化和量化髓源性抑制细胞在原发性和转移性癌症中的归巢动力学。
Theranostics. 2019 Aug 12;9(20):5869-5885. doi: 10.7150/thno.33275. eCollection 2019.
3
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.多西他赛促进淋巴管-肿瘤串扰以促进淋巴管生成和癌症进展。
BMC Cancer. 2018 Jul 6;18(1):718. doi: 10.1186/s12885-018-4619-8.
4
Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.地西他滨通过耗尽骨髓瘤微环境中的单核细胞髓系来源抑制细胞发挥强大的抗骨髓瘤活性。
J Cancer Res Clin Oncol. 2019 Feb;145(2):329-336. doi: 10.1007/s00432-018-2790-6. Epub 2018 Nov 13.
5
LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.LILRB4 通过调节 MDSCs 并抑制 miR-1 家族 miRNA 促进肿瘤转移。
Oncoimmunology. 2022 Apr 5;11(1):2060907. doi: 10.1080/2162402X.2022.2060907. eCollection 2022.
6
A heptamethine cyanine dye serves as a potential marker for myeloid-derived suppressor cells.一种七甲川花菁染料可作为髓源性抑制细胞的潜在标志物。
Am J Cancer Res. 2021 Jun 15;11(6):2853-2866. eCollection 2021.
7
Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.靶向细胞因子诱导的杀伤细胞与髓系来源抑制细胞在肝癌中的相互作用。
J Hepatol. 2019 Mar;70(3):449-457. doi: 10.1016/j.jhep.2018.10.040. Epub 2018 Nov 9.
8
A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.在小鼠模型中,乳腺癌细胞与髓源性抑制细胞之间的相互激活环通过IL-6转信号促进自发转移。
Breast Cancer Res. 2013;15(5):R79. doi: 10.1186/bcr3473.
9
Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.干扰素调节因子 4(IRF4)控制髓系来源的抑制细胞(MDSC)分化和功能。
J Leukoc Biol. 2016 Dec;100(6):1273-1284. doi: 10.1189/jlb.1A0215-068RR. Epub 2016 Sep 6.
10
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.肿瘤微环境中的白细胞介素33对髓源性抑制细胞的积累和功能至关重要。
Oncoimmunology. 2015 Jun 24;5(1):e1063772. doi: 10.1080/2162402X.2015.1063772. eCollection 2016.

引用本文的文献

1
Interstitial fluid flow in an engineered human lymph node stroma model modulates T cell egress and stromal change.工程化人淋巴结基质模型中的组织液流动调节T细胞流出和基质变化。
APL Bioeng. 2025 Apr 4;9(2):026105. doi: 10.1063/5.0247363. eCollection 2025 Jun.
2
Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer.乳腺癌淋巴转移的分子与细胞机制
Onco Targets Ther. 2025 Feb 4;18:199-209. doi: 10.2147/OTT.S503272. eCollection 2025.
3
[Myeloid-derived suppressor cells as important factors and potential targets for breast cancer progression].

本文引用的文献

1
Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression.阻断多形核髓样来源抑制细胞的迁移可抑制小鼠黑色素瘤进展。
Cancers (Basel). 2021 Feb 10;13(4):726. doi: 10.3390/cancers13040726.
2
Monocytic myeloid-derived suppressor cells home to tumor-draining lymph nodes via CCR2 and locally modulate the immune response.单核细胞来源的髓样抑制细胞通过 CCR2 归巢至肿瘤引流淋巴结,并在局部调节免疫反应。
Cell Immunol. 2021 Apr;362:104296. doi: 10.1016/j.cellimm.2021.104296. Epub 2021 Jan 30.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
髓源性抑制细胞作为乳腺癌进展的重要因素和潜在靶点
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Dec 25;53(6):785-795. doi: 10.3724/zdxbyxb-2024-0353.
4
A Photopolymerizable Hyaluronic Acid-Collagen Model of the Invasive Glioma Microenvironment with Interstitial Flow.具有间质流的光聚合透明质酸-胶原侵袭性神经胶质瘤微环境模型。
J Vis Exp. 2024 Oct 18(212). doi: 10.3791/66604.
5
Myeloid‑derived suppressor cells as targets of emerging therapies and nanotherapies (Review).髓源性抑制细胞作为新兴疗法和纳米疗法的靶点(综述)
Med Int (Lond). 2024 Jun 25;4(5):46. doi: 10.3892/mi.2024.170. eCollection 2024 Sep-Oct.
6
Model discovery approach enables noninvasive measurement of intra-tumoral fluid transport in dynamic MRI.模型发现方法能够在动态磁共振成像中对肿瘤内液体转运进行无创测量。
APL Bioeng. 2024 Apr 29;8(2):026106. doi: 10.1063/5.0190561. eCollection 2024 Jun.
7
Editorial: 'Engineering the Tumor Immune Microenvironment' Special Issue.社论:“构建肿瘤免疫微环境”特刊
Cancers (Basel). 2023 Aug 8;15(16):4014. doi: 10.3390/cancers15164014.
8
MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target.乳腺癌中的 MDSCs:肿瘤进展的重要促进因素和新兴治疗靶点。
Front Immunol. 2023 Jul 3;14:1199273. doi: 10.3389/fimmu.2023.1199273. eCollection 2023.
9
Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?通过靶向缺氧肿瘤内皮增强乳腺癌的免疫监视:它能成为一个免疫转换点吗?
Front Oncol. 2023 Mar 28;13:1063051. doi: 10.3389/fonc.2023.1063051. eCollection 2023.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.在髓系细胞多样性不断增加的时代中的髓源性抑制细胞。
Nat Rev Immunol. 2021 Aug;21(8):485-498. doi: 10.1038/s41577-020-00490-y. Epub 2021 Feb 1.
5
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.髓系来源抑制细胞的发育与归巢:从两阶段模型到多步骤叙述。
Front Immunol. 2020 Oct 26;11:557586. doi: 10.3389/fimmu.2020.557586. eCollection 2020.
6
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas.髓系来源的抑制性细胞耗竭疗法靶向表达 IL-17A 的乳腺癌。
Sci Rep. 2020 Aug 7;10(1):13343. doi: 10.1038/s41598-020-70231-7.
7
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.胶质母细胞瘤髓系来源抑制细胞亚群表达不同的巨噬细胞移动抑制因子受体谱,可靶向这些受体谱减少免疫抑制。
Front Immunol. 2020 Jun 18;11:1191. doi: 10.3389/fimmu.2020.01191. eCollection 2020.
8
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.髓源性抑制细胞作为癌症治疗靶点。
Cells. 2020 Feb 27;9(3):561. doi: 10.3390/cells9030561.
9
Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics.利用单细胞转录组学定义乳腺癌中髓系来源抑制细胞的出现。
Sci Immunol. 2020 Feb 21;5(44). doi: 10.1126/sciimmunol.aay6017.
10
Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma.癌症相关成纤维细胞通过诱导产生 ROS 的单核细胞 MDSC 促进肺鳞状细胞癌的免疫抑制。
Cancer Immunol Res. 2020 Apr;8(4):436-450. doi: 10.1158/2326-6066.CIR-19-0507. Epub 2020 Feb 19.